SciELO - Scientific Electronic Library Online

 
vol.24 número3Condicionamiento de la evolución del VIH/sida definida por criterios clínico-biológicos en adultos de la ciudad de Córdoba (Argentina), de 1995 a 2005, por la brecha sanitaria existente entre ambos sexosEvaluación de la gestión de los casos de incapacidad temporal por contingencia común de más de 15 días en Cataluña índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Articulo

Indicadores

Links relacionados

  • En proceso de indezaciónCitado por Google
  • No hay articulos similaresSimilares en SciELO
  • En proceso de indezaciónSimilares en Google

Compartir


Gaceta Sanitaria

versión impresa ISSN 0213-9111

Resumen

MAR, Javier; ANTONANZAS, Fernando; PRADAS, Roberto  y  ARROSPIDE, Arantzazu. Probabilistic Markov models in economic evaluation of health technologies: a practical guide. Gac Sanit [online]. 2010, vol.24, n.3, pp.209-214. ISSN 0213-9111.

Objective: Markov models are the standard method used in cost-effectiveness studies to represent the natural history of disease. The objective of this study was to show the key elements in building probabilistic Markov models. Methods: We used the example of a new treatment for a generic disease. A probabilistic Markov model was constructed using statistical distributions. Monte Carlo simulations were carried out to obtain the probabilistic sensitivity analysis. The results were analyzed in terms of the cost-effectiveness plane and acceptability curve. Results: The incremental cost-effectiveness rate for the average patient was €22,855/quality adjusted life years (QALY). In the probabilistic sensitivity analysis, the results from all simulations were located in the northeast quadrant, corresponding to positive cost and effectiveness. However, 67% of the simulations were below the threshold of €30,000/QALY. Conclusion: The use of probabilistic Markov models requires the integration of concepts from economics, epidemiology, statistics, and the clinical setting. Some stages of the process, such as the construction and processing of these models, the management of absolute and relative risks and of statistical distributions, often pose major difficulties but are key steps required to reproduce the disease with validity.

Palabras clave : Markov models; Decision analysis; Cost-effectiveness study; Probabilistic sensitivity analysis.

        · resumen en Español     · texto en Español     · Español ( pdf )

 

Creative Commons License Todo el contenido de esta revista, excepto dónde está identificado, está bajo una Licencia Creative Commons